PKPola Knurowska

Pola Knurowska

*This is an algorithmically generated author record based on publicly available information.

Pola Knurowska has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Parathyroid Adenoma - The Leading Cause of Primary Hyperparathyroidism: Case Report

    by Martyna Zielnik, Julia Dubel, Szymon Kalinowski, Sabina Kadłubek, Patrycja Rembisz, Anna Czuba, Pola Knurowska, Klaudia Serafin, Aleksander Wrona, Aleksandra Słowikowska

    Primary hyperparathyroidism is an endocrine disorder characterized by excessive secretion of parathyroid hormone (PTH) by the parathyroid glands, disproportionate to the physiological requirement for calcium concentration. This hypersecretion of PTH occurs independently of dysregulation in calcium-phosphate metabolism. The predominant etiology of primary hyperparathyroidism is the presence of a parathyroid adenoma. (7) This case report presents a 68-year-old female patient with a history of osteoporosis, diagnosed in 2019 for osteoarticular pain and hypercalcemia. The suboptimal response to standard osteoporosis treatment was an indication to expand the diagnosis of calcium-phosphate disorders accompanying osteoporosis. Diagnostic evaluation confirmed primary hyperparathyroidism due to parathyroid adenoma and appropriate therapeutic measures were subsequently implemented. This report highlights the nonspecific clinical presentation of the disease and the diagnostic difficulties associated with illness. A multidisciplinary approach to the patient is required due to the multifaceted nature of the disease.

  • Open Access

    Impact of maternal pharmacotherapy use during lactation on breastfeeding options and safety

    by Anna Czuba, Julia Dubel, Martyna Zielnik, Klaudia Serafin, Pola Knurowska, Patrycja Rembisz

    Due to its unique composition, breast milk is the ideal food for the baby, as it contains all the necessary nutrients. Breastfeeding is recommended by numerous scientific societies and is associated with many immediate as well as long-term benefits for mother and child. The use of pharmacotherapy in mothers during lactation raises concerns about the adverse consequences of treatment and the health of the child due to the distribution of drugs into breast milk. The following paper aims to present the safety profile of selected drug products during breastfeeding.